| |
|
|
Session 55
Poster Presentations Viral Reservoirs During Latency and Antiretroviral Therapy Tuesday 1:30 - 3:30 pm Hall A |
| 460 | Resistance of HIV Infection in Resting Memory CD4+CD62L- T-lymphocytes In Vitro to Drugs Used in HAART Gondois-Rey*, Fernandez, Biancotto, Bettendrofer, Vigne, Hirsch INSERM, Marseille, France |
| 461 | CD45RO+ Cells which are Latently Infected with HIV Co-express CD45RA Yanying Cao*, Jesus Saavedra-Lozano, Jinbo Xu, Cynthia McCoig, Octavio Ramilo, Ellen S Vitetta Univ of Texas Southwestern Med Ctr, Dallas |
| 462 | An In Vitro Model for the Study of Latent/Persistent HIV-1 Infection in Primary CD4 Cells: Quantitation of Integrated Viral DNA Using Real-time PCR KK Koelsch*1, Y Kawano1, JK Wong1,2, DD Richman1,2, CA Spina1,2 1Univ of California at San Diego, La Jolla and 2Veterans Admin San Diego Hlthcare Sys, La Jolla, CA |
| 463 | Multiply Spliced and Extracellular PBMC-associated HIV-RNAs are Specific Cellular Correlates of Productive Infection Early after Cessation of HAART M. Fischer*1, B. Joos1, B. Hirschel2, R. Weber1, H.F. Gunthard1, The Swiss HIV Cohort Study 1Univ Hosp Zurich, Switzerland and 2Univ Hosp Geneva, Switzerland |
| 464 | Longitudinal Study of Replication Competent HIV from CD4 T-cell "Latent" Reservoirs in HIV-infected Children on HAART N Ching*1, L S Wei1, J Deville1, K Nielsen1, S Wolinsky2, R Dickover1, Y J Bryson1 1Univ of California at Los Angeles and 2Northwestern Univ, Chicago, IL |
| 465 | The Persistence of Morphological and T-lymphocyte Subsets Abnormalities in Lymphoid Tissue in HIV-1 Infected Patients Successfully Treated with HAART Correlate with Lymphoid Tissue Viral Replication L. Alós, V. Morente, F. García*, M. Caballero, G. Mestre, A. Cruceta, M. Arnedo, T. Pumarola, M. Plana, T. Gallart, E. Martínez, J. Mallolas, J. L. Blanco, J. M. Miró, J. M. Gatell Inst d'Investigacions Biomèdiques August Pi i Sunyer, Hosp Clín, Univ of Barcelona, Spain |
| 466 | Persistence of Stable, Quantifiable Viremia in Patients on Antiretroviral Therapy Despite Suppression of Plasma HIV-1 RNA to less than 50 Copies/ml F. Maldarelli*1, A. Wiegand1, S. Palmer1, M. Kearney1, V. Boltz1, M. Polis2, J. Falloon2, J. Mican2, R. Davey2, D. Rock2, S. Liu3, A. Planta3, J. Metcalf3, J. Mellors4, J. Coffin1 1HIV Drug Resistance Prgm, NCI, NIH, Frederick, MD; 2Lab of Immunoregulation, NIAID, NIH, Bethesda, MD; 3Natl Inst of Allergy and Infectious Diseases/CCMD Clin NIH, Bethesda, MD; and 4Univ of Pittsburgh, PA |
| 467 | CCR7 Expression of T-cells and CD16 Expression on CD14+ Monocytes Determine the Predominant Cellular Reservoirs of HIV-1 In Vivo K. Shults*1, D. Derbin2, L. Flye1, B. Patterson2 1Esoterix Ctr for Innovation, Brentwood, TN and 2Children's Mem Hosp, Northwestern Univ, Chicago, IL |
| 468 | Monocyte Subsets and HIV Reservoirs in Patients on HAART P. Ellery1, S. Sonza1, J. Mills2, S. Crowe*1 1Macfarlane Burnet Inst for Med Res and Publ Hlth, Melbourne, Australia and 2Monash Med Sch, Alfred Hosp, Melbourne, Austrailia |